Acrux Limited (ACR.AX)
AUD 0.02
(4.55%)
AUD 0.02
(4.55%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -1.45 Million AUD | 119.57% |
| 2023 | -3.87 Million AUD | -3.36% |
| 2022 | -3.75 Million AUD | 71.21% |
| 2021 | -13.03 Million AUD | -91.57% |
| 2020 | -6.8 Million AUD | 62.51% |
| 2019 | -18.15 Million AUD | 36.24% |
| 2018 | -28.47 Million AUD | 16.2% |
| 2017 | -33.97 Million AUD | -15.72% |
| 2016 | -29.36 Million AUD | -27.28% |
| 2015 | -23.06 Million AUD | 10.5% |
| 2014 | -25.77 Million AUD | -12.85% |
| 2013 | -22.84 Million AUD | 23.91% |
| 2012 | -30.01 Million AUD | 9.48% |
| 2011 | -33.15 Million AUD | 43.42% |
| 2010 | -58.6 Million AUD | -297.73% |
| 2009 | -14.73 Million AUD | 57.12% |
| 2008 | -34.36 Million AUD | -99.49% |
| 2007 | -17.22 Million AUD | 12.73% |
| 2006 | -19.73 Million AUD | 29.67% |
| 2005 | -28.06 Million AUD | -327.63% |
| 2004 | -6.56 Million AUD | 39.4% |
| 2003 | -10.83 Million AUD | 39.32% |
| 2002 | -17.84 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 759 Thousand AUD | 119.57% |
| 2024 Q4 | -1.45 Million AUD | 0.0% |
| 2024 Q2 | -2.3 Million AUD | 0.0% |
| 2023 FY | -3.87 Million AUD | -3.36% |
| 2023 Q4 | -3.87 Million AUD | 0.0% |
| 2023 Q2 | -2.36 Million AUD | 0.0% |
| 2022 Q4 | -3.75 Million AUD | 0.0% |
| 2022 FY | -3.75 Million AUD | 71.21% |
| 2022 Q2 | -8.44 Million AUD | 0.0% |
| 2021 Q4 | -13.03 Million AUD | 0.0% |
| 2021 FY | -13.03 Million AUD | -91.57% |
| 2021 Q2 | -9.14 Million AUD | 0.0% |
| 2020 FY | -6.8 Million AUD | 62.51% |
| 2020 Q2 | -11.98 Million AUD | 0.0% |
| 2020 Q4 | -6.8 Million AUD | 0.0% |
| 2019 Q2 | -22.22 Million AUD | 0.0% |
| 2019 Q4 | -18.15 Million AUD | 0.0% |
| 2019 FY | -18.15 Million AUD | 36.24% |
| 2018 FY | -28.47 Million AUD | 16.2% |
| 2018 Q4 | -28.47 Million AUD | 0.0% |
| 2018 Q2 | -32.36 Million AUD | 0.0% |
| 2017 Q2 | -31.71 Million AUD | 0.0% |
| 2017 FY | -33.97 Million AUD | -15.72% |
| 2017 Q4 | -33.97 Million AUD | 0.0% |
| 2016 Q4 | -29.36 Million AUD | 0.0% |
| 2016 FY | -29.36 Million AUD | -27.28% |
| 2016 Q2 | -21.53 Million AUD | 0.0% |
| 2015 FY | -23.06 Million AUD | 10.5% |
| 2015 Q4 | -23.06 Million AUD | 0.0% |
| 2015 Q2 | -15.79 Million AUD | 0.0% |
| 2014 FY | -25.77 Million AUD | -12.85% |
| 2014 Q4 | -25.77 Million AUD | 0.0% |
| 2014 Q2 | -17.48 Million AUD | 0.0% |
| 2013 Q4 | -22.84 Million AUD | 0.0% |
| 2013 FY | -22.84 Million AUD | 23.91% |
| 2013 Q2 | -19.04 Million AUD | 0.0% |
| 2012 FY | -30.01 Million AUD | 9.48% |
| 2012 Q4 | -30.01 Million AUD | 0.0% |
| 2011 Q4 | -33.15 Million AUD | 0.0% |
| 2011 FY | -33.15 Million AUD | 43.42% |
| 2010 Q4 | -58.6 Million AUD | 0.0% |
| 2010 FY | -58.6 Million AUD | -297.73% |
| 2009 Q4 | -14.73 Million AUD | 0.0% |
| 2009 FY | -14.73 Million AUD | 57.12% |
| 2008 FY | -34.36 Million AUD | -99.49% |
| 2008 Q4 | -34.36 Million AUD | 0.0% |
| 2007 FY | -17.22 Million AUD | 12.73% |
| 2007 Q4 | -17.22 Million AUD | 0.0% |
| 2006 Q4 | -19.73 Million AUD | 0.0% |
| 2006 FY | -19.73 Million AUD | 29.67% |
| 2005 FY | -28.06 Million AUD | -327.63% |
| 2005 Q4 | -28.06 Million AUD | 0.0% |
| 2004 FY | -6.56 Million AUD | 39.4% |
| 2004 Q4 | -6.56 Million AUD | 0.0% |
| 2003 FY | -10.83 Million AUD | 39.32% |
| 2002 FY | -17.84 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -72.509% |
| Actinogen Medical Limited | -9.13 Million AUD | 84.034% |
| AnteoTech Limited | -5 Million AUD | 70.849% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 90.837% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 88.533% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -48.456% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 88.317% |
| Amplia Therapeutics Limited | -1.82 Million AUD | 20.048% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 72.642% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -105.48% |
| Biome Australia Limited | -1.56 Million AUD | 6.706% |
| Biotron Limited | -386.06 Thousand AUD | -277.654% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 98.162% |
| BTC Health Limited | -2.02 Million AUD | 27.899% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | 52.244% |
| CSL Limited | 15.76 Billion AUD | 100.009% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 98.932% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 99.203% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 76.504% |
| Dimerix Limited | -21.99 Million AUD | 93.37% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 92.285% |
| Hexima Limited | -2.22 Million AUD | 34.508% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -17.732% |
| Immuron Limited | -11.48 Million AUD | 87.304% |
| Immutep Limited | -122.18 Million AUD | 98.807% |
| Imugene Limited | -91.56 Million AUD | 98.408% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 75.801% |
| Memphasys Limited | 4.13 Million AUD | 135.257% |
| Nanollose Limited | -96.22 Thousand AUD | -1415.199% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 91.471% |
| Noxopharm Limited | -2.31 Million AUD | 37.153% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | 70.57% |
| Nyrada Inc. | -4.76 Million AUD | 69.43% |
| Orthocell Limited | -19.92 Million AUD | 92.682% |
| PharmAust Limited | -9.71 Million AUD | 84.991% |
| Patrys Limited | -2.24 Million AUD | 34.93% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 91.707% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 76.944% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 85.653% |
| PYC Therapeutics Limited | -65.76 Million AUD | 97.783% |
| Race Oncology Limited | -17.18 Million AUD | 91.518% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 92.151% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | 57.069% |
| Starpharma Holdings Limited | -19.83 Million AUD | 92.648% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 98.622% |
| Tissue Repair Ltd | -16.44 Million AUD | 91.132% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 128.773% |